Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
about
The role of regulatory T cells in the pathogenesis of sepsis and its clinical implicationNeutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling.Type I interferon signaling in hematopoietic cells is required for survival in mouse polymicrobial sepsis by regulating CXCL10.Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth.Persistent neutrophil dysfunction and suppression of acute lung injury in mice following cecal ligation and puncture sepsis.Impact of sepsis on CD4 T cell immunityMonitoring immune dysfunctions in the septic patient: a new skin for the old ceremony.A paradoxical role for myeloid-derived suppressor cells in sepsis and traumaB cells enhance early innate immune responses during bacterial sepsis.The role of regulatory T cells in immune dysfunction during sepsis.CCR4 Controls the Suppressive Effects of Regulatory T Cells on Early and Late Events during Severe Sepsis.Thermal injury-plus-sepsis contributes to a substantial deletion of intestinal mesenteric lymph node CD4 T cell via apoptosisAnnexin A2 Modulates ROS and Impacts Inflammatory Response via IL-17 Signaling in Polymicrobial Sepsis Mice.TNF and regulatory T cells are critical for sepsis-induced suppression of T cellsSepsis-induced immune dysfunction: can immune therapies reduce mortality?Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists.Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive careBlood stream infection is associated with altered heptavalent pneumococcal conjugate vaccine immune responses in very low birth weight infants.Adoptive transfer of fibrocytes enhances splenic T-cell numbers and survival in septic peritonitis.Sepsis induces early alterations in innate immunity that impact mortality to secondary infection.Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis.Interleukin-37 Enhances the Suppressive Activity of Naturally Occurring CD4+CD25+ Regulatory T Cells.Endogenous IL-10 regulates sepsis-induced thymic apoptosis and improves survival in septic IL-10 null mice.The immune system's role in sepsis progression, resolution, and long-term outcome.Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock.Thymic Stromal Lymphopoietin Improves Survival and Reduces Inflammation in Sepsis.Adoptive transfer of CD34(+) cells during murine sepsis rebalances macrophage lipopolysaccharide responses.Immune cells and oxidative stress in the endotoxin tolerance mouse model.Potential Immunotherapeutics for Immunosuppression in Sepsis.Sepsis leads to a reduced antigen-specific primary antibody response.T regulatory cells participate in the control of germinal centre reactions.Small-molecule inhibitor sorafenib regulates immunoreactions by inducing survival and differentiation of bone marrow cells.
P2860
Q27004368-6A8D310C-1A77-4759-BBF0-E5C5B016D9AEQ30419805-61D9B6E3-5090-4FC5-BB6D-2FF9376ED455Q33656087-A177DA1A-8940-4B97-8200-22C8241AEB61Q33828888-5D15F156-2907-498A-93BA-C80744EAD778Q33896697-5E9DE513-E2A7-43F3-9F31-750290717892Q34076226-8609E916-9B52-453D-B14D-6CB84D4FE523Q34341378-6CB94A98-1EF3-40ED-BCDE-0EBE8344A17EQ34585151-86F9CDBF-1021-4ADE-B3F0-1D609E538ABAQ34699543-BF323C04-2D63-4622-A385-74E35ECA7430Q35144572-8536F2E7-58DE-4E6D-BE94-BF91AE5791EDQ35205781-83DC8EC6-1AEC-4D7C-BABE-F184714827E7Q35703434-8ADD27B6-5B3B-4C20-B5D4-D6563225A348Q36007864-EF9620AC-4CDA-43DF-8773-839C294A6CA6Q36070617-101FE5C0-9733-46F5-9D1A-161F8E338479Q36410571-0F03EF69-B572-4DB2-92A5-9FCC86F78F52Q36430684-3D22DFAA-BC5C-4975-B1D6-9FED1B47D1ABQ36843705-5FEF5A76-EF37-4735-8E55-383C945C4154Q36995660-93F82C93-8C9D-46A8-82F5-C1DEF107F3E8Q37042911-52C80E8A-C5A1-4BAD-920D-7D7AA75B67A8Q37069103-519A3BEA-0BB7-466C-9DC2-F64F205002D4Q37166367-FFD49620-70AB-4A05-BD4A-BBBB3219B1A1Q37260284-529ED02A-6296-4BDE-AF5D-F22215F9422FQ37492932-061923D6-7BC3-48BB-9075-AC3640C1A3BEQ37618990-BA4B3195-3791-4E02-AC5B-D4329E71EBDAQ38991057-2182DE9A-CCE8-4B2B-8C15-EECDB0A6DA83Q39779016-E73E860E-28CF-4007-9A98-3EEB50D604E7Q40770616-39FACD14-65B1-4CFA-9C9E-F560A207AF5FQ44880503-A2CC2256-A2DA-4C10-90FA-D505D8EF32F1Q46431958-51997A97-9017-4820-9832-5E532C4E8D95Q47102338-8A05A74B-2AED-4604-B468-5D6D974803D5Q50981888-ADA1CE1C-AD41-4599-BF29-D00AC33CD8A5Q51006330-1CC84BFE-1D9E-4DC5-B552-CB6AF73B97ECQ51627647-D5AED83C-AB9C-4F17-8EAA-06AAC91C08A2
P2860
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
@ast
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
@en
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
@nl
type
label
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
@ast
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
@en
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
@nl
prefLabel
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
@ast
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
@en
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
@nl
P2093
P2860
P1433
P1476
Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis.
@en
P2093
Changqing Xia
Chun Shiang Chung
James L Wynn
Jason S Weinstein
Kindra M Kelly-Scumpia
Lyle L Moldawer
Mark A Atkinson
Matthew J Delano
Michael J Clare-Salzler
Philip O Scumpia
P2860
P304
P356
10.1182/BLOOD-2007-04-087171
P407
P50
P577
2007-08-09T00:00:00Z